Products for epilepsy patients arrives in Australia
17 June 2020
Media Title: Cannabis Intel Media Type: Online Publish Date: 28 January 2019 Headline: Affordable products for epilepsy patients arrives in Australia Abstract: MGC Pharma has also collaborated with Epilepsy Action Australia to develop C4E (cannabis for epilepsy), to provide education to epilepsy sufferers and their families on medicinal cannabis and its interaction with the illness.Read More…
Read More >